Company
Cosmos Holdings, Inc.
Headquarters: Chicago, IL, United States
Employees: 89
CEO: Mr. Grigorios Siokas
Market Cap
$16.0 Million
USD as of Jan. 1, 2024
Cosmos Holdings, Inc. Categories
United States Healthcare Drug Manufacturers—Specialty & GenericUnited States Healthcare United States Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. It offers proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications, and medical devices with EU distribution network. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes and has a network of clients in Germany, the United Kingdom, the United Arab Emirates, Denmark, Italy, France, Singapore, Ireland, Sweden, Poland, the Netherlands, and Greece, as well as has distribution centers in Thessaloniki, Greece, Athens, Greece and Harlow, the United Kingdom. The company was formerly known as Prime Estates and Developments, Inc. and changed its name to Cosmos Holdings Inc. in November 2013. Cosmos Holdings Inc. was incorporated in 2009 and is based in Chicago, Illinois.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Cosmos Holdings, Inc. has the following listings and related stock indices.
Stock: OTC: COSM wb_incandescent